PetVivo Holdings, Inc. (PETV) Earnings Call Transcripts

PetVivo Holdings, Inc.'s Latest Earnings Call - June 16, 2026

In the Q1 FY2026 earnings call, PetVivo Holdings, Inc. (PETV:US) highlighted significant advancements in its Spryng technology, which is gaining traction among veterinarians for treating osteoarthritis in pets. The company reported an increase in product adoption, with management emphasizing that Spryng provides a viable alternative to pharmaceuticals, addressing a critical market need. While specific revenue figures were not disclosed, management indicated strong momentum in sales and a commitment to expanding distribution channels, particularly in the U.S. and internationally. Guidance for the upcoming quarters remains optimistic, with expectations for continued growth driven by new partnerships and product developments.

Reported metrics

Guidance from management

Management remains optimistic about future growth, emphasizing the importance of expanding partnerships and increasing product adoption. They expect to see tangible advancements in the next year as they continue to educate both veterinarians and pet owners.

What management said

Sure. My name is Dr. Juli Goldstein. I've been a veterinarian for over 20 years in both small animal practice and academic settings. And with PetVivo, I serve as the technical services veterinarian where I get to work with veterinarians every day that are implementing our products and helping to drive those discussions and case selections.

Yes, Bryan Monninger. I'm a lifelong pet and animal lover and have over 25 years' experience within the animal industry. And then currently, the VP of Sales and Distributor relations for PetVivo. So manage the entire sales team as well as our technical veterinarians.

What analysts pressed on

Analysts expressed concerns regarding the pace of adoption and the need for more concrete revenue figures to assess the company's financial health. There were also questions about the competitive landscape and how PetVivo plans to differentiate itself in a growing market.

Main topics on the call

• Product Adoption and Market Demand — Management noted that veterinarians are increasingly incorporating Spryng into their treatment protocols, stating, "Spryng has provided another option in that toolbox to work concurrently with all the other things that v...
• Strategic Partnerships — The company is focusing on expanding its partnership with Piezo Bio, which is expected to enhance product offerings. CEO John Lai stated, "One of the first ones to look for is probably really enhance and expanding our pa...
• Global Distribution Strategy — PetVivo has established partnerships with major U.S. veterinary distributors and is expanding into international markets, including the U.K., EU, and Canada. Bryan Monninger mentioned, "We're basically now partnered stra...
• Veterinary Education Initiatives — The company is actively working on educating veterinarians about Spryng and its benefits, with ongoing continued education credits being offered. John Lai emphasized, "Our goal... is to also educate the consumers, the pe...

Read the full PetVivo Holdings, Inc. transcript (June 16, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 16 PetVivo Holdings, Inc. earnings call transcripts on record, spanning November 10, 2022 to June 29, 2026. Based on this history, PetVivo Holdings, Inc. reports quarterly. The most recent call on file is dated June 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

PETV

Exchange

OTCPK

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

16

First call

November 10, 2022

Most recent

June 29, 2026

Reporting cadence

quarterly